Loading...
Loading...
NVRO| Name | Value |
|---|---|
| Revenues | 116.2M |
| Cost of Revenue | 37.7M |
| Gross Profit | 78.5M |
| Operating Expense | 90.2M |
| Operating I/L | -11.8M |
| Other Income/Expense | -3.8M |
| Interest Income | 3.9M |
| Pretax | -15.6M |
| Income Tax Expense | -6.6M |
| Net Income/Loss | -9.0M |
Nevro Corp. is a medical device company that develops and commercializes the Senza spinal cord stimulation system, Senza II, and Senza Omnia systems for the treatment of chronic pain. The company also offers 10 kHz Therapy, providing evidence-based neuromodulation solutions. Nevro Corp. generates revenue by selling its products through a direct sales force, as well as a network of sales agents and independent distributors, both in the United States and internationally.
